entity

MAO-A

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MAO-A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections
0Hypotheses
0Analyses
5Outgoing
3Incoming

Wiki Pages (20)

Knowledge base pages for this entity

rasagiline

therapeutic · 4916 words

Mitsubishi Tanabe Pharma Corporation

company · 3329 words

methylene-blue-neurodegeneration

therapeutic · 3259 words

Reactive Oxygen Species (ROS) Pathway

mechanism · 3211 words

Dopamine Pathway

mechanism · 2877 words

Outgoing (5)

TargetRelationTypeStr
neuronal cellexpressed_incell_type0.90
Alzheimer's Diseaseimplicated_indisease0.85
Alzheimer's Diseasetherapeutic_targetdisease0.80
LOXinteracts_withprotein0.70
benchmark_ot_ad_answer_key:MAO-Adata_indataset_row0.00

Incoming (3)

SourceRelationTypeStr
Aβ42 oligomersmodulatescompound0.80
APPassociated_withgene0.75
benchmark_ot_ad_answer_key:MAO-Adata_indataset_row0.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found